Andrew Baum, MD, has served as the head of global healthcare and managing director of equity research at Citi, where he’s been working since 2011. In June, he will join Pfizer and succeed Aamir Malik, who recently became the drugmaker’s chief U.S. commercial officer, executive vice president.
In his new role, Dr. Baum will lead Pfizer’s portfolio management team, the company said in a news release.
Before Citi, Dr. Baum covered European Pharmaceuticals at Morgan Stanley for 14 years; prior to that role, he was a physician.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
